Currently, if you take a look at it, artificial intelligence (AI) can examine regular coronary angiograms to forecast important heart health signs with over 80% precision. Researchers from the Mayo Clinic have formulated algorithms for AI that are able to predict four key cardiovascular biomarkers by extracting valuable information from angiograms.
Dr. Mohamad Alkhouli of the Mayo Clinic presented these findings at a recent medical conference. Dr. Alkhouli’s team employed AI in analyzing 20,000 angiograms and taught it how to measure such heart functions as left ventricular performance, right ventricular performance and cardiac output. In order to verify its accuracy, they matched up its results against traditional methods like echocardiography and right heart catheterization.
The models revealed extremely accurate projection scores in various categories of heart function by the AIs; nevertheless they are yet being polished up so that many measures can be predicted along with integrating them into a user-friendly dashboard for real-time use within catheterization lab setting.
Other steps the researchers plan on taking include creating algorithms which would be capable of predicting different cardiac diseases as well as building up necessary IT infrastructure required for this work; a process that is estimated to take between one and two years’ time span.
In spite of some concerns about this technology however Dr Alkhouli says “I think there’s still value in allowing machines do our thinking for us sometimes – especially when we consider how much procedural work needs doing now!” He emphasised that it should always be seen as supplementing human intellect instead of supplanting or replacing doctors altogether.
However, there are challenges facing widespread adoption within healthcare systems mainly due better data integration coupled with infrastructure development required around these areas where they may not even be present currently warns another specialist Dr Ian Gilchrist affiliated with Penn State Health who believes whilst having great potentialities on offer which cannot go unnoticed indeed have not been tapped into fully because limited investments made towards them so far from the side of medical establishments themselves.
Source: medscape
